The CD8 cell antiviral factor: an interview with immunologist Jay Levy, MD. Interview by Mark Mascolini.
Levy
J
J
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology* / Q000628:therapy / Q000635:transmission; D000818:Animals; D015703:Antigens, CD / Q000276:immunology*; D001685:Biological Factors / Q000302:isolation & purification*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002478:Cells, Cultured; D005260:Female; D015497:HIV-1 / Q000502:physiology*; D015498:HIV-2 / Q000502:physiology; D006801:Humans; D008297:Male; D014779:Virus Replication
D015703:Antigens, CD; D001685:Biological Factors